AGP Picks
View all

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on October 16, 2026

OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director
Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Types
Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026
Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation
Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis
Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease
Aurora Mobile’s JPush Enhances Channel Communications and End-User Reach for Prinx Chengshan
Kling AI Launches Kling 4.0 Globally with Professional-Grade Output, Stable Motion and Multimodal Control
Turkish Airlines and CFM sign MOU for more than 600 LEAP-1B engines
STS Digital Named North America's Best Digital Assets Trading Platform/Venue by Euromoney
Hotdesk.com expandiert auf über 2.000 Standorte in ganz Europa, angeführt von Großbritannien, Spanien, Frankreich, Deutschland und Italien
Hotdesk.com Expands to 2,000+ Locations Across Europe, Led by the UK, Spain, France, Germany and Italy
Hotdesk.com étend son réseau à plus de 2 000 sites en Europe, notamment au Royaume-Uni, en Espagne, en France, en Allemagne et en Italie
ONERugged Launches V82T and M10A-VDS Rugged Devices for Fleet Management and Vehicle Diagnostics
ZERO13 named World’s Best Venue for Sustainability in Euromoney Markets Awards 2026
Senturi Pharma announces exclusive European distribution agreement for PERTZYE®
Three Orelabrutinib Studies Presented in Oral Sessions at the 88th Annual Meeting of the Japanese Society of Hematology
Norsk Hydro: Reminder - Invitation to Hydro's third quarter results 2026
Microbiotica Raises £36 Million ($48 Million) in Series C Financing to Advance Pipeline into Phase 2 Clinical Development
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Enrolls First Patient in Phase Ib/II Combination Trial in Metastatic Colorectal Cancer

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Science

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.